CBAY

Cymabay Therapeutics
CBAY

Overview Fund Activity
Delisted

CBAY was delisted on the 21st of March, 2024.

Back to rankings

139 hedge funds and large institutions have $775M invested in Cymabay Therapeutics in 2023 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 43 increasing their positions, 37 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
139
Holders Change
+21
Holders Change %
+17.8%
% of All Funds
2.22%
Holding in Top 10
10
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+66.67%
% of All Funds
0.16%
New
42
Increased
43
Reduced
37
Closed
20
Calls
$6.51M
Puts
$3.42M
Net Calls
+$3.09M
Net Calls Change
+$1.8M

Top Buyers

1
Janus Henderson Group
Janus Henderson Group
United Kingdom
$65.4M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
$38.4M
3
Franklin Resources
Franklin Resources
California
$28.1M
4
PA
Perceptive Advisors
New York
$34M
5
OCA
Octagon Capital Advisors
New York
$39.9M

Top Sellers

1
CC
Commodore Capital
New York
$17.7M
2
TCM
TCG Crossover Management
California
$26.6M
3
BBA
Baker Bros. Advisors
New York
$0
4
GPP
Great Point Partners
Connecticut
$4.43M
5
Citadel Advisors
Citadel Advisors
Florida
$2.84M
Name Holding Trade Value Shares
Change 		Shares
Change %
ACA
1
Avoro Capital Advisors
New York
$89.8M – – –
Janus Henderson Group
2
Janus Henderson Group
United Kingdom
$65.4M +$54.5M +6,252,380 +503%
OCA
3
Octagon Capital Advisors
New York
$39.9M +$23.6M +2,711,718 +146%
Vanguard Group
4
Vanguard Group
Pennsylvania
$38.8M +$6.75M +774,310 +21%
Adage Capital Partners
5
Adage Capital Partners
Massachusetts
$38.4M +$34M +3,899,400 +780%
PA
6
Perceptive Advisors
New York
$34M +$27.9M +3,194,262 +451%
Franklin Resources
7
Franklin Resources
California
$28.1M +$27.9M +3,201,765 +13,862%
TCM
8
TCG Crossover Management
California
$26.6M -$24.9M -2,857,143 -48%
Millennium Management
9
Millennium Management
New York
$25.7M +$17.6M +2,018,868 +217%
BlackRock
10
BlackRock
New York
$23.1M +$5.53M +634,577 +31%
BCLSI
11
Bain Capital Life Sciences Investors
Massachusetts
$21.8M +$21.8M +2,500,000 New
CC
12
Commodore Capital
New York
$17.7M -$32.4M -3,713,500 -65%
Balyasny Asset Management
13
Balyasny Asset Management
Illinois
$17.1M +$16.6M +1,901,769 +3,439%
LCM
14
Laurion Capital Management
New York
$16.8M +$2.67M +306,203 +19%
NCM
15
Nantahala Capital Management
Connecticut
$15.6M -$4.02M -460,456 -20%
FCMI
16
Foresite Capital Management IV
California
$15.6M – – –
SVCM
17
Saturn V Capital Management
Texas
$14.2M +$154K +17,686 +1%
Two Sigma Investments
18
Two Sigma Investments
New York
$12.4M +$8.99M +1,030,443 +265%
Two Sigma Advisers
19
Two Sigma Advisers
New York
$12.3M +$8.82M +1,011,300 +251%
LCM
20
Lynx1 Capital Management
Puerto Rico
$11.9M -$2.47M -283,568 -17%
CAM
21
Cormorant Asset Management
Massachusetts
$11.1M +$11.1M +1,271,429 New
Susquehanna International Group
22
Susquehanna International Group
Pennsylvania
$10.3M +$6.83M +782,755 +195%
Dimensional Fund Advisors
23
Dimensional Fund Advisors
Texas
$10.3M -$1.14M -131,286 -10%
AAA
24
Affinity Asset Advisors
New York
$9.44M -$527K -60,413 -5%
Morgan Stanley
25
Morgan Stanley
New York
$8.65M +$6.27M +719,302 +263%
1
2 3 4 5